Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14441-08-8

Post Buying Request

14441-08-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14441-08-8 Usage

Description

(S)-N-Z-3-AMINO 3-PHENYLPROPIONIC ACID, with the molecular formula C9H11NO2, is an amino acid derivative characterized by the presence of a phenyl group attached to the carbon adjacent to the amine group. (S)-N-Z-3-AMINO 3-PHENYLPROPIONIC ACID is significant in pharmaceutical research and development, serving as a crucial building block for the synthesis of various bioactive molecules and pharmaceutical drugs. Its unique stereochemistry and specific functional groups contribute to its value in organic synthesis, particularly in the production of pharmaceutical compounds.

Uses

Used in Pharmaceutical Research and Development:
(S)-N-Z-3-AMINO 3-PHENYLPROPIONIC ACID is used as a building block for the synthesis of bioactive molecules and pharmaceutical drugs. Its unique structural properties and potential biological activities make it a valuable compound in the development of new medications.
Used in Medicinal Chemistry and Drug Discovery:
In the field of medicinal chemistry and drug discovery, (S)-N-Z-3-AMINO 3-PHENYLPROPIONIC ACID is utilized as a key intermediate due to its stereochemistry and specific functional groups. These characteristics enable the compound to play a significant role in the design and synthesis of novel pharmaceutical agents.
Used in Organic Synthesis:
(S)-N-Z-3-AMINO 3-PHENYLPROPIONIC ACID is also employed in organic synthesis, where its structural properties and functional groups are harnessed to produce a wide range of pharmaceutical compounds. Its versatility as an intermediate makes it a valuable asset in the development of new and innovative medications.

Check Digit Verification of cas no

The CAS Registry Mumber 14441-08-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,4,4 and 1 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 14441-08:
(7*1)+(6*4)+(5*4)+(4*4)+(3*1)+(2*0)+(1*8)=78
78 % 10 = 8
So 14441-08-8 is a valid CAS Registry Number.

14441-08-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S)-3-{[(Benzyloxy)carbonyl]amino}-3-phenylpropanoic acid

1.2 Other means of identification

Product number -
Other names N-(benzyloxycarbonyl)-D-3-amino-3-phenylpropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14441-08-8 SDS

14441-08-8Relevant articles and documents

Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity

Huang, Boshi,Wang, Huiqun,Zheng, Yi,Li, Mengchu,Kang, Guifeng,Barreto-De-Souza, Victor,Nassehi, Nima,Knapp, Pamela E.,Selley, Dana E.,Hauser, Kurt F.,Zhang, Yan

, p. 7702 - 7723 (2021/06/28)

Crystal structures of ligand-bound G-protein-coupled receptors provide tangible templates for rationally designing molecular probes. Herein, we report the structure-based design, chemical synthesis, and biological investigations of bivalent ligands targeting putative mu opioid receptor C-C motif chemokine ligand 5 (MOR-CCR5) heterodimers. The bivalent ligand VZMC013 possessed nanomolar level binding affinities for both the MOR and CCR5, inhibited CCL5-stimulated calcium mobilization, and remarkably improved anti-HIV-1BaL activity over previously reported bivalent ligands. VZMC013 inhibited viral infection in TZM-bl cells coexpressing CCR5 and MOR to a greater degree than cells expressing CCR5 alone. Furthermore, VZMC013 blocked human immunodeficiency virus (HIV)-1 entry in peripheral blood mononuclear cells (PBMC) cells in a concentration-dependent manner and inhibited opioid-accelerated HIV-1 entry more effectively in phytohemagglutinin-stimulated PBMC cells than in the absence of opioids. A three-dimensional molecular model of VZMC013 binding to the MOR-CCR5 heterodimer complex is constructed to elucidate its mechanism of action. VZMC013 is a potent chemical probe targeting MOR-CCR5 heterodimers and may serve as a pharmacological agent to inhibit opioid-exacerbated HIV-1 entry.

Stereoselective synthesis and in vivo evaluation of the analgesic activity of polysubstituted bispidines

Plas, Aurelie,Troin, Yves,Chalard, Pierre,Marchand, Fabien,Eschalier, Alain

, p. 6070 - 6079,10 (2020/09/02)

Hetero-Michael addition on a chiral β'-amino α,β- unsaturated ketone gave, after some structural modifications, β,β'-diamino ketals. Mannich-type reactions of these diamines with an aldehyde led, with high diastereoselectivity, to trisubstituted piperidines. Another highly stereoselective Mannich cyclization, with an N-acyliminium ion generated in situ from the corresponding imide, allowed the preparation of original polycyclic bispidine derivatives. The antinociceptive effect of the three compounds prepared was evaluated in vivo by using the writhing test. If the biological results for the analgesic properties were disappointing, compared with the bispidine HZ2, which has a high affinity for opioid receptors, the modularity of the approach offered the possibility of introducing many substituents for new applications, which was promising because the bispidine core has been described to have many different activities. Total stereoselective synthesis of bispidine derivatives is achieved by using as two successive Mannich reactions key steps. This process constitutes a powerful approach toward the preparation of a polycyclic bispidine backbone with high enantioselectivity.

Homologation of α-amino acids to β-amino acids: 9-Fluorenylmethyl chloroformate as a carboxyl group activating agent for the synthesis of Nα-protected aminoacyldiazomethanes

Kantharaju,Suresh Babu, Vommina V.

, p. 2152 - 2158 (2007/10/03)

An efficient and stereospecific homologation of urethane-protected α-amino acids to β-amino acids by Arndt-Eistert approach using an equimolar mixture of Fmoc-/Boc-/Z-α-amino acid and 9-fluorenylmethyl chloroformate for the acylation of diazomethane synth

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14441-08-8